CTX-II

Publications

A biomarker perspective on the acute effect of exercise with and without impact on joint tissue turnover: an exploratory randomized cross-over study
A dual amylin and calcitonin receptor agonist inhibits pain behavior and reduces cartilage pathology in an osteoarthritis rat model
Application of biochemical markers in development of drugs for treatment of osteoarthritis
Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis
Biochemical markers in preclinical models of osteoporosis
Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity
Clinical and biochemical factors associated with risk of total joint replacement and radiographic progression in osteoarthritis: Data from two phase III clinical trials
Collagen and tissue turnover as function of age - implications for fibrosis
Does moderate intensity impact exercise and non-impact exercise induce acute changes in collagen biochemical markers related to osteoarthritis? - An exploratory randomized cross-over trial
GPDPLQ1237-A Type II Collagen Neo-Epitope Biomarker of Osteoclast- and Inflammation-Derived Cartilage Degradation in vitro
Investigating the Robustness and Diagnostic Potential of Extracellular Matrix Remodelling Biomarkers in Alkaptonuria
Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein
Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significance
Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats
Osteoarthritis Year in Review 2016: biomarkers (biochemical markers)
Serological biomarkers detect active joint destruction and inflammation in patients with haemophilic arthropathy
The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants
Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials

Therapeutic area
Rheumatology

Biomarker panels

Function
Cartilage Degradation, ECM degradation

Alternative names
uCTX-II, u-CTX-II

Certification
-

Platform
ELISA

Sample type
Urine

Sample volume
50 µl

Healthy reference range
Reach out to learn more

Species (Tested in)
N/A

Biomarker Portfolio

Publications

Publications

Most popular subjects

How can we help you?

How can we help you?

Biomarker Portfolio

Therapeutic Areas

Oncology

Rheumatology

Hepatic diseases

Respiratory Diseases

Gastroenterology

Cardiovascular

Renal diseases

Neuroscience

Services

Technology

About

CTX-II

Publications

Publications

Most popular subjects

How can we help you?

How can we help you?